Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO

Mereo Biopharma Group Plc (MREO) Stock Forecast & Price Target

399 Followers
See the Price Targets and Ratings of:
See bloggers sentiment and opinion on MREO
>

MREO Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Mereo
Biopharma Group Plc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MREO Stock 12 Months Forecast

There Are No Analyst Ratings for MREO In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MREO Financial Forecast

MREO Earnings Forecast

Next quarter’s earnings estimate for MREO is -$0.01 with a range of -$0.04 to $0.03. The previous quarter’s EPS was -$0.02. MREO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.62% of the time in the same period. In the last calendar year MREO has Underperformed its overall industry.
Next quarter’s earnings estimate for MREO is -$0.01 with a range of -$0.04 to $0.03. The previous quarter’s EPS was -$0.02. MREO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.62% of the time in the same period. In the last calendar year MREO has Underperformed its overall industry.

MREO Sales Forecast

Next quarter’s sales forecast for MREO is $22.77M with a range of $0.00 to $45.54M. The previous quarter’s sales results were $8.79M. MREO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year MREO has Outperformed its overall industry.
Next quarter’s sales forecast for MREO is $22.77M with a range of $0.00 to $45.54M. The previous quarter’s sales results were $8.79M. MREO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year MREO has Outperformed its overall industry.

MREO Analyst Recommendation Trends

MREO has not received any ratings in the last 3 months.
MREO has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners
Buy
Reiterated
SVB Securities Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)
Needham
$5.00
Buy
275.94%
Upside
Reiterated
Needham Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)
BTIG
$4.00
Buy
200.75%
Upside
Reiterated
Analysts Are Bullish on Top Healthcare Stocks: Homology Medicines (FIXX), Mereo Biopharma Group Plc (MREO)
Cantor Fitzgerald
$4.00
Buy
200.75%
Upside
Reiterated
Cantor Fitzgerald Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)

Best Analysts Covering Mereo Biopharma Group Plc

Which Analyst Should I Follow If I Want to Buy MREO and Sell After:
1 Month
Joseph SchwartzLeerink Partners
Success Rate
6/12 ratings generated profit
50%
Average Return
+1.99%
reiterated a buy rating 4 months ago
Copying Joseph Schwartz's trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.99% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Gil BlumNeedham
Success Rate
6/11 ratings generated profit
55%
Average Return
+22.55%
reiterated a buy rating 4 months ago
Copying Gil Blum's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +22.55% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Gil BlumNeedham
Success Rate
7/11 ratings generated profit
64%
Average Return
+29.67%
reiterated a buy rating 4 months ago
Copying Gil Blum's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +29.67% per trade.
2 Years
Gil BlumNeedham
Success Rate
9/11 ratings generated profit
82%
Average Return
+66.50%
reiterated a buy rating 4 months ago
Copying Gil Blum's trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +66.50% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MREO Stock Forecast FAQ

What is MREO’s average 12-month price target, according to analysts?
Currently, no data Available
What is MREO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MREO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MREO a Buy, Sell or Hold?
      Currently, no data Available
      What is Mereo Biopharma Group Plc’s price target?
      Currently, no data Available
      What do analysts say about Mereo Biopharma Group Plc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MREO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis